Dr. Fernando Lopez-Diaz is the Director of Clinical Science and R&D at NeoGenomics Laboratories, specializing in clinical molecular oncology, cancer genomics, and biomarker development. With a PhD and postdoctoral training at The Salk Institute, he is a recognized leader in translational research and technological innovation in oncology.
Demonstrating a significant entrepreneurial spirit, Fernando founded Argentinas first clinical genomics-based cancer care and research center. He is passionate about fostering international scientific collaboration, frequently speaking at global conferences like ASCO, AMP, and AACR to connect with peers and discuss the latest advancements in precision medicine.
His pioneering single-cell RNA sequencing study on drug resistance was named a "Stellar Breakthrough" by the Salk Institute.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.